Srivastava Kamal, Teper Ariel A, Zhang Teng-Fei, Li Side, Walsh Martin J, Huang Chih-Kang, Kattan Meyer, Schofield Brian H, Sampson Hugh A, Li Xiu-Min
Department of Pediatrics, Mount Sinai School of Medicine, New York, NY, USA.
J Allergy Clin Immunol. 2004 Feb;113(2):268-76. doi: 10.1016/j.jaci.2003.10.062.
T(H)2 cytokines play a central role in the pathogenesis of allergic asthma. We previously showed that the "antiasthma" Chinese herbal formula MSSM-002 exhibited therapeutic effects on established allergic airway responses in a murine model of allergic asthma. However, the mechanisms underlying these effects are largely unknown.
The objective of this study was to determine whether and how MSSM-002 modulates an established T(H)2 response and whether the actions of MSSM-002 on T(H)2 cell differs from corticosteroids.
T(H)2 polarized splenocytes (T(H)2-SPCs) from mice with antigen-induced airway hyperresponsiveness and T(H)2 cloned cells, D10 G4.1 (D10), were cultured in the presence or absence of antigen with or without MSSM-002 and dexamethasone, and the proliferative responses and cytokine profiles were determined. Apoptosis and T(H)2 transcription factor GATA-3 expression and binding to IL-4 gene promoter and V(A) enhancer in MSSM-002-treated D10 cells were also determined.
MSSM-002 significantly decreased antigen-induced proliferation and IL-4 and IL-5 production but increased IFN-gamma production by T(H)2-SPCs, whereas dexamethasone suppressed IFN-gamma as well as IL-4 and IL-5. Anti-IL-12 antibody, although abrogating MSSM-002 induction of IFN-gamma, had no significant effect on MSSM-002 suppression of IL-4 and IL-5 secretion. MSSM-002 also suppressed T(H)2 cytokine secretion by D10 cells, and in contrast to dexamethasone, MSSM-002 did not induce apoptosis of D10 cells. MSSM-002 markedly suppressed GATA-3 mRNA and protein expression and the binding to IL-4 gene promoter and V(A) enhancer in D10 cells.
MSSM-002, in contrast to the overall suppression of T cells by dexamethasone, exhibits immunomodulatory actions on T(H)2 cells caused, at least partially, by downregulation of GATA-3.
辅助性T细胞2(Th2)细胞因子在过敏性哮喘的发病机制中起核心作用。我们之前表明,“抗哮喘”中药配方MSSM - 002在过敏性哮喘小鼠模型中对已建立的过敏性气道反应具有治疗作用。然而,这些作用的潜在机制在很大程度上尚不清楚。
本研究的目的是确定MSSM - 002是否以及如何调节已建立的Th2反应,以及MSSM - 002对Th2细胞的作用是否与皮质类固醇不同。
将来自抗原诱导气道高反应性小鼠的Th2极化脾细胞(Th2 - SPCs)和Th2克隆细胞D10 G4.1(D10)在有或无抗原、有或无MSSM - 002和地塞米松的情况下培养,然后测定增殖反应和细胞因子谱。还测定了MSSM - 002处理的D10细胞中的凋亡情况以及Th2转录因子GATA - 3的表达及其与IL - 4基因启动子和V(A)增强子的结合情况。
MSSM - 002显著降低抗原诱导的增殖以及Th2 - SPCs产生的IL - 4和IL - 5,但增加其IFN - γ的产生,而地塞米松则抑制IFN - γ以及IL - 4和IL - 5。抗IL - 12抗体虽然消除了MSSM - 002诱导的IFN - γ,但对MSSM - 002抑制IL - 4和IL - 5分泌没有显著影响。MSSM - 002还抑制D10细胞分泌Th2细胞因子,与地塞米松不同的是,MSSM - 002不诱导D10细胞凋亡。MSSM - 002显著抑制D10细胞中GATA - 3 mRNA和蛋白表达以及其与IL - 4基因启动子和V(A)增强子的结合。
与地塞米松对T细胞的全面抑制不同,MSSM - 00对Th2细胞具有免疫调节作用,这至少部分是由GATA - 3的下调引起的。